Ad
related to: pfizer stock price
Search results
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Motley Fool via Yahoo Finance· 1 day agoPfizer stock lost nearly half its value over the past couple of years, but some of the world's most...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 1 day agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 hours agostock picks each month. The Stock Advisor service has more than quadrupled the return of S&P 500 since 2002*. *Stock Advisor returns ...
Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It
Zacks· 5 days agoThe Zacks Large Cap Pharmaceuticals industry, to which Pfizer belongs, has gained 6.3% over this period. Now the key question is: Where could the stock ...
The Highest Paid CEOs of 2023
The Wall Street Journal· 1 day agoThey were joined by four utilities. Pfizer said it didn’t pay bonuses to top executives last year after weak demand for Covid...for CEO Stéphane Bancel...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 21 hours agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
Pfizer Settles Zantac Lawsuits, Agrees To $250M Settlement To Reduce Liability: Report - Pfizer...
Benzinga· 6 days agoIn a bid to settle thousands of lawsuits over its discontinued heartburn drug Zantac, Pfizer Inc....
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Motley Fool via Yahoo Finance· 2 days agoPfizer Shares of the pharmaceutical giant, Pfizer offer a 5.9% dividend yield at recent prices. It...
Pfizer Inc.’s latest rating changes from various analysts – Knox Daily
Knox Daily· 2 days agoArgus downgraded its Pfizer Inc. [PFE] rating to a Hold from a a Buy in a research...revised their coverage, including Guggenheim’s analysts, who began to cover the
This overlooked obesity-drug stock has 80% upside, JPMorgan says
Business Insider via Yahoo Finance· 13 hours agoThe bank initiated coverage of the near-$2 billion biotech company with an "Overweight" rating and...